MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 23, 2009; DOI: 10.1124/mol.109.057802


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.109.057802v1
76/3/526    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Fan, P.
Right arrow Articles by Yao, L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fan, P.
Right arrow Articles by Yao, L.


Received for publication May 18, 2009.
Revised June 18, 2009.
Accepted for publication June 23, 2009.

Up-regulation of AGS3 during morphine withdrawal promotes cAMP superactivation via adenylyl cyclase 5 and 7 in rat nucleus accumbens/striatal neurons

Peidong Fan 1, Zhan Jiang 1, Ivan Diamond 1, Lina Yao 1*

1 CV Therapeutics, Inc.

* Address correspondence to: E-mail: lina.yao{at}gilead.com

Abstract

Effective medical treatment of opiate addiction is limited by a high relapse rate in abstinent addicts. Opiate withdrawal causes cAMP superactivation, but the underlying molecular mechanisms are not clear. Recent evidence implicates an activator of G-protein signaling 3 (AGS3) in opiate addiction. Previously, we found that during a 10 min activation of opioid receptors, AGS3 binds G{alpha}i-GDP to promote free G{beta}{gamma} stimulation of adenylyl cyclase (AC) 2 and 4, and/or inactivate G{alpha}i inhibitory function, thereby transiently enhancing cAMP-dependent protein kinase A (PKA) activity. In contrast, we report here that in NAc/striatal neurons morphine withdrawal induces cAMP superactivation which requires up-regulation of AGS3. cAMP increases as a function of withdrawal time, by approximately 20% at 10 min and 75% at 5 h. However, cAMP superactivation does not require G{beta}{gamma}. Instead, adenosine A2A receptor activation of G{alpha}s/olf appears to initiate cAMP superactivation and promote AGS3 up-regulation. Elevated AGS3 binds to G{alpha}i to prevent its inhibition on AC activation. Moreover, withdrawal-induced increases in cAMP/PKA activate PLC and {epsilon} protein kinase C ({epsilon}PKC) to further stimulate AC5 and AC7, causing cAMP superactivation. Our findings identify a critical role of AC 5 and 7 and A2A receptors for up-regulation of AGS3 in morphine withdrawal-induced cAMP superactivation.


Key words: Adenosine, Adenylyl cyclases, cAMP, Protein Kinase A, Protein Kinase C, Opioids





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics